Novo CEO pressed by Senate to chop costs of obesity, diabetes medicine CEO Lars Fruergaard Jørgensen told lawmakers the business would take into account new talks with insurers about the list rates of Wegovy and copyright should they pledge to keep the medicines on their formularies. Financial investment in digital https://titusgnmjg.thezenweb.com/what-does-healthcare-news-mean-68519143